• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    LC and LC–MS/MS studies for the identification and characterization of degradation products of acebutolol

    2018-12-10 12:02:32UdyRkibeRviTiwriAnndMhjnVipulRnePrvinWkte
    Journal of Pharmaceutical Analysis 2018年6期

    Udy Rkibe,Rvi Tiwri,Annd Mhjn,Vipul Rne,Prvin Wkte

    aDepartment of Chemical Technology,Dr.Babasaheb Ambedkar Marathwada University,Aurangabad,Maharashtra,India

    bDepartment of Pharmaceutical Sciences,SVKM’s NMIMS,Shirpur,Dist.Dhule,Maharashtra,India

    cDepartment of Pharmaceutical Analysis,Goa College of Pharmacy,Panjim,Goa,India

    Keywords:Acebutolol Stress testing LC LC–MS/MS Degradation pathway In-silico toxicity

    A B S T R A C T The aim of the present investigation was to demonstrate an approach involving use of liquid chromatography(LC)and liquid chromatography-mass spectrometry(LC–MS)to separate,identify and characterize very small quantities of degradation products(DPs)of acebutolol without their isolation from the reaction mixtures.The drug was subjected to oxidative,hydrolytic,thermal and photolytic stress conditions as per International Conference on Harmonization(ICH)guideline Q1A(R2).Among all the stress conditions the drug was found to be labile in hydrolytic(acidic&basic)and photolytic stress conditions,while it was stable in water-induced hydrolysis,oxidative and thermal stress conditions.A total of four degradation products were formed.A C18column was employed for the separation of all the DPs on a gradient mode by using high-performance liquid chromatography(HPLC).All the DPs were characterized with the help of their fragmentation pattern and the masses obtained upon LC–MS/MS and MSnanalysis.All the hitherto unknown degradation products were identified as 1-(2-(2-hydroxy-3-(isopropylamino)propoxy)-5-(amino)phenyl)ethanone (DP-I), N-(4-(2-hydroxy-3-(isopropylamino)propoxy)-3-acetylphenyl)acrylamide (DP-II),1-(2-(2-hydroxy-3-(isopropylamino)propoxy)-5-(hydroxymethylamino)phenyl)ethanone(DP-III)and 1-(6-(2-hydroxy-3-(isopropylamino)propoxy)-2,3-dihydro-2-propylbenzo[d]oxazol-5-yl)ethanone(DP-IV).Finally the in-silico carcinogenicity and hepatotoxicity predictions of the drug and all the DPs were performed by using toxicity prediction softwares viz.,TOPKAT,LAZAR and Discovery Studio ADMET.The results of in-silico toxicity studies revealed that acebutolol(0.967)and DP-I(0.986)were found to be carcinogenic,while acebutolol(0.490)and DP-IV(0.437)were found to be hepatotoxic.

    1.Introduction

    Acebutolol hydrochloride is a selective,hydrophilic beta-adrenoreceptor blocker which is used to treat hypertension and ventricular arrhythmias.Other beta-adrenergic agents are atenolol,betaxolol,celiprolol,bisoprolol,esmolol,metoprolol,nebivolol,etc.Chemically acebutolol(Fig.1)is N-[3-Acetyl–4-[2–hydroxy–3-[(1–methylethyl)amino]propoxy]-butanamide[1].There exist various reports on investigation and analysis of acebutolol by using different analytical techniques such as high-performance liquid chromatography(HPLC),thin layer chromatography,ion pair HPLC,liquid chromatography with tandem mass spectrometry(LC–MS/MS),voltammetry,and polarography.The drug is reported for the enantioselective determination of its active metabolite diacetolol in spiked human plasma samples by LC–MS/MS[2–6],determination in pharmaceutical formulations and biological fluids by voltammetric method[7],and major metabolite determination in infant’s blood circulation and breast milk by a stereospecific HPLC assay method[8].There are HPLC methods reported for acebutolol doping analysis and toxicological investigations of fatal cases of acebutolol self-poisoning[9,10].A literature report is also available on comparative HPLC and LC–MS analysis of antiepileptic with beta-blocking drugs[11].Acebutolol is also explored by ion-pair HPLC method for its determination in pharmaceuticals[12].However,very few reports are on acebutolol stability studies and its determination in acid induced degradation products(DPs)and identification of radiodegradation products by irradiation of high dose ionizing radiation emitted by beam of high energy electrons[13–15].

    Fig.1.Structure of acebutolol.

    Hence,the endeavor of the present study was to separate,identify and characterize DPs of acebutolol formed under ICH Q1A(R2)[16]recommended stress conditions of hydrolysis(acid,base and neutral),oxidation,dry heat and photolysis.Moreover,the parallel objective of this study was to explore comprehensive information on the degradation pathway of the drug.To achieve this task a systematic outline of the study includes(i)degradation study of acebutolol under conditions of oxidation,hydrolysis,thermal and photolysis,(ii)separation of DPs and validation of the developed LC method,(iii)characterization of DPs by LC–MS/MS and MSnstudies,(iv)proposal of degradation pathway of the drug,and(v)prediction of in-silico carcinogenicity and hepatotoxicity of the drug and DPs by different models.

    2.Experimental

    2.1.Drug and reagents

    Pure acebutolol was purchased from Sigma-Aldrich(Mumbai,India).Analytical reagent(AR)grade sodium hydroxide(NaOH),ammonium formate(NH4HCO2),formic acid(HCOOH)and HPLC grade methanol were purchased from Merck Specialities Pvt.Ltd.(Mumbai,India).AR grade hydrochloric acid(HCl)and 30%hydrogen peroxide were purchased from Qualigens Fine Chemicals Pvt.Ltd.(Mumbai,India)and S.D.Fine-Chem.Ltd.(Mumbai,India),respectively.Ultra-pure double distilled HPLC grade water obtained from Labsil Instruments(Bangalore,India)was used throughout the studies.

    2.2.Equipments

    An HPLC system(Shimadzu Corporation,SPD-M20A,Kyoto,Japan)equipped with LC Solution software was used for LC studies equipped with a photo-diode array(PDA)detector,sample injector with 20 μL loop,and on-line degasser containing binary pump.The output signals were assessed on a Dell computer using LC Solution software.Stress degradation studies were carried out using precision water bath(Meta-Lab Ltd.,Mumbai,India)containing a thermostat for temperature control.A hot air oven(Scientico Ltd.,Mumbai,India)was used to perform solid state thermal stress studies.Photodegradation studies were executed in a photostability chamber(Thermolab Scientific Equipments Pvt.Ltd.,Mumbai,India),where the temperature was adjusted to 25± 2°C during the study.The measurement of visible and near UV illumination energy was carried out by using a calibrated lux and UV meter(Thermolab Scientific Equipments Pvt.Ltd.,Mumbai,India)[17].The LC–MS system controlled by Xcalibur software(version 2.0)consisted of LCQ Fleet and TSQ Quantum Access with Surveyor Plus HPLC System(Thermo,San Jose,USA).All the separation studies were carried out using a C18column(150 mm×4.6 mm i.d.,particlesize5 μm)Kromasil(Eka Chemicals AB,Bohus,Sweden).A pH meter(Controlled Dynamics,Vadodara,India)was used to adjust the pH of mobile phase and all other solutions used during the study.Other equipments used during the study were weighing balance(Shimadzu,AUX220,Kyoto,Japan),sonicator(Spectralab UCB 30,Mumbai,India)and analytical balance(Precissa XR 205SMDR,Moosmattstrasse Dietikon,Switzerland).

    2.3.Forced degradation studies

    The objective of forced degradation studies was to achieve 10%–15%degradation of the drug.The drug was subjected to oxidative,hydrolytic,thermal and photolytic stresses.The results were obtained by comparing four samples of every stress condition viz.,untreated blank sample,stressed blank sample,untreated standard drug sample and stressed drug sample solution.In case of thermal and photolytic stress conditions only two samples were generated viz.,sample exposed to stress condition and control sample.

    2.3.1.Hydrolytic degradation

    The hydrolytic decomposition was performed in acidic,alkaline and neutral conditions.Samples were prepared by taking 1mL of stock solution of drug(1000μg/mL)and 1 mL of hydrolytic agent(1 M HCl,1 M NaOH and water)in 10 mL volumetric flask.If required,the samples were heated at constant temperature on water bath at 80°C for specified time intervals.The samples were neutralized by using equal strength of acid or alkali before injected into HPLC system.

    2.3.2.Oxidative degradation

    Oxidative degradation was carried out by using hydrogen peroxide.Samples were prepared by taking 1mL of stock solution of the drug(1000μg/mL)and 1 mL of hydrogen peroxide(30%)in 10 mL volumetric flask.If required,the samples were heated on constant temperature water bath at 80°C for specified time intervals.After required exposure samples were diluted up to the mark by using diluent and subjected for HPLC analysis.

    2.3.3.Thermal degradation

    Drug sample of 10 mg each was taken in two 10 mL volumetric flasks and sealed.One flask was exposed to dry heat in hot air oven for specified temperature and time interval and the other was kept as control.After required exposure two separate solutions were prepared by weighing appropriate amounts of the sample exposed to thermal stress and control to produce concentration of 100μg/mL.The samples were diluted up to the mark with the help of diluent and injected separately into HPLC.

    2.3.4.Photodegradation

    The drug layer of 1 mm thickness was prepared in a petri dish and exposed to ICH recommended photostability conditions with the overall illumination of not less than 1.2 million lx h along with the integrated near ultraviolet energy of not less than 200 W h/m2.Another petri dish containing the drug(1 mm layer thickness)was wrapped with aluminum foil and kept as control.After required exposure two separate solutions were prepared by weighing appropriate amounts of the sample exposed to stress and control to produce concentration of 100μg/mL.The samples were diluted up to the mark with the help of diluent and injected separately into HPLC.

    Photodegradation of the drug was also carried out in solution phase.Two solutions with the concentration of 100μg/mL were prepared in 10 mL volumetric flask by using methanol as diluent.One was exposed to ICH dose of light and the other was kept as control.

    2.4.HPLC method development

    HPLC studies were carried out individually on all the reaction solutions and then on the mixture of those solution in which the degradation was observed.A duplicate sample of each stress condition was injected into HPLC system along with a separate blank stress sample to achieve an optimum degradation.To accomplish an appropriate separation and to resolve all the polar DPs overlapping/merging,various HPLC trials were conducted.The separation was executed using different proportions of acetonitrile(ACN),methanol(MeOH)and ammonium formate buffer(10 mM)by varying the pH of buffer with formic acid.The detection wavelength,injection volume and flow rate were 235nm,20 μL and 1 mL/min,respectively.

    2.5.HPLC method validation

    The developed LC method was validated by covering various parameters outlined in the ICH guidelines Q2(R1)[18].The selected validation parameters included linearity,precision(interday and intra-day),accuracy,specificity,and selectivity.

    2.5.1.Linearity

    Linearity of the method was established by using solutions containing 50–250μg/mL of the drug.Each linearity sample was injected in triplicate into the HPLC column by keeping the injection volume constant.

    2.5.2.Precision

    A precision study was carried out by injecting the drug with three different concentrations(100,150 and 200 μg/mL)in triplicate into the HPLC on the same day and the next day.The values of standard deviation(SD)and percent relative standard deviation(%RSD)were calculated for both intra-day and inter-day precision.

    2.5.3.Accuracy

    The accuracy of the method was established by conducting recovery studies of pure drug from degradation samples by standard addition method.The mixtures of stressed samples were spiked with the drug with concentrations of 80,120and 160μg/mL.

    2.5.4.Specificity and selectivity

    The specificity of the method was investigated through establishment of resolution factor between the drug peak and the nearest resolving peak,and also among other peaks.Selectivity was confirmed through peak purity studies using a PDA detector.A mixture of degradant was produced by mixing an equal amount of solutions generated during different stress conditions and subjected for HPLC analysis.

    2.6.Mass spectral studies on the drug

    Mass spectral studies were performed in positive electrospray ionization(ESI)mode in the mass range of 50–1000 Da to establish the fragmentation pattern of the drug.In order to get clear mass spectrum without any background noise,the drug at a concentration of 5μg/mL in methanol:water(50:50,v/v)was directly infused using a syringe pump into the mass spectrometer.The mass parameters were appropriately tuned to get clear molecular ion peak of the drug.High purity nitrogen was used as the nebulizer and auxiliary gas.The drug was further subjected to MS/MS analysis in positive ESI mode to explore the origin of each individual fragment.

    2.7.LC–MS/MS studies

    The degraded drug samples were subjected to LC–MS/MS analysis in positive ESI mode using the previously developed gradient LC method.A satisfactory separation of degradation products was achieved by using C18column.For structure elucidation of the DPs,the samples with maximum degradation were subjected to LC–MS analysis.The structural identity of each DP was performed with the LC–MS fragmentation analysis.

    2.8.In-silico toxicity studies

    The drug and all its degradation products were subjected to insilico carcinogenicity and hepatotoxicity predictions by using different models.Carcinogenicity prediction was performed by using Toxicity Prediction by Komputer Assisted Technology(TOPKAT)version 6.2,Lazar Toxicity Prediction software version 1.1.2 building on top of the OpenTox framework and adopting DSSTox database,TOPKAT Extensible built with Bayesian models and partial least square(PLS)technique.Hepatotoxicity prediction was carried out by using Discovery Studio ADMET.The model was developed from available literature data of 382 compounds known to exhibit liver toxicity or trigger dose-related elevated aminotransferase levels in more than 10%of the human population[19].

    3.Results and discussion

    3.1.Degradation behaviour

    The chromatogram in Fig.2 reveals the degradation behaviour of acebutolol.A total of four degradation products were generated from the drug(denoted as I-IV according to the elution order in the chromatogram).A major degradation product(DP-I)was formed in both acid and alkaline stress conditions,while the other major degradation product(DP-IV)was generated only in alkaline stress condition.Two minor degradation products,DP-II and DP-III,were formed only in photolytic stress condition.This shows that the acebutolol is photo labile to a certain extent and an indication for the bulk drug substance and generic drug product manufacturers to optimize the critical quality attributes(CQA)to avoid the significant light exposure during the manufacturing process.Apart from the above listed stress conditions the drug was found to be stable in neutral(heating in water),oxidative and thermal stress conditions.

    Fig.2.HPLC chromatogram of all the acebutolol products(I-IV)and acebutolol.

    Fig.3.Line spectrum of acebutolol obtained in MS study.

    3.2.Fragmentation pathway of the drug

    As shown in Fig.3,a total of 10 fragments were formed from the drug.Molecular ion fragment of the drug(numbered as 0)had the mass of 337.21,which followed a parallel fragmentation pathway.The two fragments of m/z 116.11 and m/z 319.20 were formed from the drug due to the cleavage of ether linkage of the side chain and loss of hydroxyl group,respectively(Fig.4).Two types of fragment ions can be easily identified in Fig.4,viz.,side chain fragment ions and cyclic structure fragment ions.The fragment with m/z 116.11 on loss of isopropyl resulted in ion with m/z 74.06,in which lone pair of electrons of nitrogen succeeded in cyclic structure(m/z 72.04)formation with the terminal hydroxyl group.In the alternate fragmentation pathway of ion with m/z 116.11,the ions with m/z 98.10 and m/z 56.05 were formed on loss of hydroxyl and isopropyl groups,respectively.In this fragmentation part,the bond cleavages took place between carbon and heteroatom linkages,which are considered to be loose links as compared to C–C bond.On the other hand,the fragment with m/z 319.20 was formed from the drug on loss of hydroxyl group,and then in the subsequent step the fragment with m/z 319.20 underwent cleavage of isopropyl amine and isopropyl entities from the terminal side chain to form a cyclic fragment ion with m/z 260.13 and m/z 277.16,respectively.Finally,the fragment with m/z 260.13 on loss of a propyl group from the side chain led to the ion with m/z 218.08.The interpretation of MS/MS data of fragments of the drug is shown in Table 1,and the complete fragmentation pathway of the drug is shown in Fig.4.

    Fig.4.Fragmentation pathway of acebutolol.

    Table 1 Interpretation of MS/MS data of fragments of acebutolol.

    3.3.LC–MS/MS studies on stressed samples

    The mass spectra of all the four degradation products,DP-I-IV,are shown in Fig.5.The experimental masses,best possible molecular formulae,theoretical mass,RDB(ring plus double bonds)and major fragments of all the DPs are listed in Table 2.

    Fig.5.Line spectra of degradation products:(A)DP-I,(B)DP-II,(C)DP-III and(D)DP-IV obtained in LC–MS/MS studies.

    Table 2 LC–MS/MS data of DPs(I-IV)along with their possible molecular formulae and major fragments.

    3.4.Identification of degradation products

    The identification of all the degradation products was achieved with the help of their fragments obtained in LC–MS/MS studies and comparison with fragmentation pattern of the drug obtained in MS/MS and MSnanalysis.

    3.4.1.DP-I(m/z 267.17)

    As shown in the mass spectrum of DP-I in Fig.5A,the fragmentation pathway of DP-I was established and the same is shown in Fig.6.The mass spectrum of DP-I revealed the formation of formate ion adduct with m/z 311.08,which had~44 Da mass units higher than DP-I.This adduct was observed in all the DPs and formed due to ammonium formate mobile phase used during HPLC separation studies.In the initial positive ESI LC–MS analysis of DP-I,a total of three fragments were formed viz.,m/z 267.17,231.08 and 116.25,which could not provid sufficient information about the source of fragment ions.Hence,in the subsequent analysis,ion with m/z 267.17 was fragmented in ion trap MS system,which led to the formation of source ions with m/z 249.11,190.10,148.16,116.23 and 98.23.A similar approach was applied to explore the sources of ions for rest of the DPs.The base peak of fragment with m/z 267.17(DP-I)was formed as an amide hydrolysis product with the cleavage of butyraldehyde moiety from the drug.The fragment with m/z 267.17 underwent a loss of water molecule and resulted in the formation of ion with m/z 249.11.This ion(m/z 249.11)underwent a parallel pathway and led to the formation of the other two daughter ions of m/z 231.08 and m/z 116.23 on loss of a water molecule and 1-(3-aminophenyl)ethanone,respectively.The ion with m/z 231.08 on loss of ethenamine(C-N cleavage)resulted in daughter ion with m/z 190.10.This parallel pathway was concluded with the loss of an acetyl moiety from ion with m/z 109.10 and led to the formation of daughter ion with m/z 148.16.Finally loss of water molecule from ion with m/z 116.25 resulted in the formation of ion with m/z 98.23.

    3.4.2.DP-II(m/z 319.17)

    As per the mass spectrum of DP-II shown in Fig.5B,and its fragmentation pattern depicted in Fig.6,a formation of formate ion adduct with m/z 363.17 was observed which had~44 Da mass units higher than DP-II.Under photolytic conditions as recommended by ICH Q1B,a direct light catalyzed oxidation resulted in loss of a terminal methyl group along with two protons,leading to the formation of DP-II with m/z 319.17.In the subsequent pathway,DP-II resulted in the formation of several daughter ions viz.,m/z 295.17,277.17,266.89,226.79,and 195.08.The few remaining ions viz.,m/z 158.70,91.06 and 69.67 might result from background noise;hence they were not considered in the fragmentation pathway.A loss of propan-2-amine and ethene moiety led to the formation of fragments with m/z 266.89 and m/z 295.17,respectively.The fragment with m/z 295.17 on multiple cleavages viz.,formaldehyde,water molecule and methyl group led to the formation of ion with m/z 195.08.On the other side,fragment with m/z 277.17 was formed on loss of a methyl group and to compensate this loss,lone pair of electrons of nitrogen underwent cyclization with the terminal methyl to form aziridine ring.The fragment with m/z 226.79 was also formed from m/z 295.17 in a two-step process,which involved an initial loss of methyl group followed by cleavage of isopropyl entity.The proposed structures and fragmentation pathways are outlined in Fig.6.

    Table 3 Linearity data for acebutolol.

    3.4.3.DP-III(m/z 297.17)

    The mass spectrum of DP-III shown in Fig.5C,revealed the formation of formate ion adduct with m/z 341.17 which had~44 Da mass units higher than DP-III.A direct cleavage of propyl group from amide side chain of the drug resulted in the formation of enol form of DP-III with m/z 297.17.DP-III on loss of N-methylpropan-2-amine moiety enabled the newly generating fragment to exhibit epoxide ring moiety which was evident in the ion fragment with m/z 224.17,while DP-III on loss of water molecule led to the formation of ion fragment with m/z 279.14.There onwards fragments ion(m/z 279.14)followed a parallel pathway of fragmentation with the loss of isopropyl amino group and 1-(2-hydroxy-5-(methylamino)phenyl)ethanone to form daughter ions with m/z 220.04 and m/z 116.21,respectively.A cleavage of methyl amino group from ion fragment m/z 220.04 resulted in ion with m/z 193.06,while loss of water molecule from m/z 116.21 led to the formation of ion with m/z 98.27.The proposed structures and fragmentation pathways are outlined in Fig.6.

    3.4.4.DP-IV(m/z 337.17)

    As the line spectra shown in Fig.5D and fragmentation pathway depicted in Fig.6 for DP-IV,DP-IV had the mass similar to the drug(m/z 337.21)along with formate ion adduct of~44 Da that other DPs also showed.Based on the similarity of mass,DP-IV was considered as a structural isomer of acebutolol.The side chain carbonyl oxygen underwent cyclization with adjacent phenyl ring to form DP-IV with m/z 337.17.In the subsequent steps,DP-IV on loss of side chain hydroxyl group resulted in the formation of fragment with m/z 319.17 which in the later step led to the loss of N-isopropylprop-1-en-1-amine and resulted in the formation of another cyclic fragment with m/z 216.14.On the other hand,a cleavage on ether linkage of the side chain and loss of 1-(isopropylamino)propan-2-ol from DP-IV led to the formation of ions with m/z 116.25 and 224.33,respectively.

    3.5.Method development and validation

    The drug and all its degradation products were found to show an acceptable separation by using acetonitrile(A)and ammonium formate buffer(B)(10 mM)with the pH 3.5 in a linear gradient mode(Tmin/A:B:T0/5:95;T10/25:75;T30/55:45;T35/5:95).The LC method validation was performed with respect to the parameters such as linearity,precision,accuracy,specificity and selectivity.In linearity studies,the selected drug concentrations showed an appropriate linear response,and the sensitivity of the method viz.,limit of detection(LOD)and limit of quantitation(LOQ),was established from the linearity data.The values of slope and correlation coefficient(r)were 86,347 and 0.998,respectively,whereas the theoretical calculated concentrations for LOD and LOQ were found to be 13.44μg/mL and 40.74μg/mL,respectively.The linearity data obtained for the concentrations from 50μg/mL to 250μg/mL is shown in Table 3.For inter-day and intra-day precision studies,the%RSD values were 0.73%–1.88%and 0.12%–1.03%,respectively.The accuracy study revealed the percent recovery of the spiked drug in the mixture of stressed samples in the range of 101.07%–101.58%with the mean recovery of 101.32%.The three known concentrations of the spiked drug were 80,120 and 160μg/mL.The developed LC method was found to be specific for each peak with respect to peak purity data obtained using a PDA detector.The relative retention time,peak purity,resolution and single point threshold data of drug and DPs are shown in Table 4.The developed method could be applied to other synthetic small molecules having similar physicochemical properties for the assay,identification and characterization of drug substance and degradation products without their isolation from the reaction mixtures.The developed method and the characterization technique are suitable for the quantification and identification of acebutolol bulk drug substance containing the degradants/impurities reported in this article.

    Table 4 Method specificity and peak purity data.

    3.6.Degradation pathway of the drug

    The degradation pathway of the drug under various stress conditions is shown in Fig.7.DP-I was formed as an amide hydrolysis product on loss of butyraldehyde moiety from the drug,while DP-II was the product obtained on cleavage of acetyl moiety from the drug.DP-III was formed from the drug on loss of propyl group along with a water molecule and DP-IV was obtained as a dehydration product from the drug.

    3.7.In-silico carcinogenicity and hepatotoxicity

    The carcinogenicity results obtained from TOPKAT,Lazar Toxicity and TOPKAT Extensible model software revealed that the drug(0.967)and DP-I(0.986)were found to be carcinogenic,while DPII to DP-IV were non-carcinogenic.As per TOPKAT model assessment the values below 0.3 indicate non-carcinogen and above 0.7 signify carcinogen,while the values between 0.3 and 0.7 are considered in intermediate zone.All the compounds under investigation(acebutolol and its DPs)were found to be non-carcinogenic(inactive)as per Lazar Toxicity Prediction model and TOPKAT Extensible model.The results obtained in hepatotoxicity study by using Discovery Studio ADMET model revealed that the drug and all DPs were non-toxic.As per Discovery Studio ADMET,the computed probabilities for toxic and non-toxic values were 0.5 or more and 0.5 or less,respectively.But the results obtained for drug(0.490)and DP-IV(0.437)indicated high probability of hepatotoxic potential.The in-silico carcinogenicity and hepatotoxicity results are depicted in Table 5.

    Fig.7.Degradation pathway of acebutolol.

    Table 5 In-silico carcinogenicity and hepatotoxicity study data of acebutolol and its DPs.

    4.Conclusions

    A forced degradation study on acebutolol was performed to determine its labile behaviour under respective stress condition.The drug was labile to acidic,alkaline and photolytic stresses,while it was stable in other neutral,oxidative and thermal conditions.The LC separation studies revealed the formation of four degradation products from the drug.DP-I was formed in acidic and basic conditions and DP-IV was generated only in basic condition.The two remaining minor DPs,DP-II and DP-III,were the products of photolytic degradation.The structures of all these degradants were resolved with the help of MS,MSn,and LC–MS/MS analysis.The complete degradation pathway of the drug was established.The in-silico carcinogenicity study explored the carcinogenic potential of the drug and DP-I,while the values obtained by Discovery Studio software for the drug and DP-IV revealed a high probability of hepatotoxic potential.

    Conflicts of interest

    The authors declare that there are no conflicts of interest.

    国产伦在线观看视频一区| 国产高清有码在线观看视频| 一本—道久久a久久精品蜜桃钙片| 69精品国产乱码久久久| 寂寞人妻少妇视频99o| h日本视频在线播放| av有码第一页| 精品酒店卫生间| 久久亚洲国产成人精品v| 免费看不卡的av| 日韩成人伦理影院| 免费看不卡的av| 国产在线男女| 精品亚洲成a人片在线观看| 亚洲国产欧美日韩在线播放 | 亚洲第一区二区三区不卡| 欧美老熟妇乱子伦牲交| 亚洲丝袜综合中文字幕| 亚洲国产毛片av蜜桃av| 亚洲精品国产av蜜桃| 国产无遮挡羞羞视频在线观看| 国产成人aa在线观看| 女性被躁到高潮视频| 国产精品一区二区在线不卡| 国产一区亚洲一区在线观看| 爱豆传媒免费全集在线观看| 国产国拍精品亚洲av在线观看| 欧美少妇被猛烈插入视频| 有码 亚洲区| 色哟哟·www| 熟妇人妻不卡中文字幕| 国产精品一二三区在线看| 少妇熟女欧美另类| 日韩一区二区三区影片| 丝袜在线中文字幕| 国产精品蜜桃在线观看| 精品人妻熟女av久视频| a 毛片基地| 乱系列少妇在线播放| 三级国产精品片| 男人和女人高潮做爰伦理| 亚洲四区av| 亚洲欧美日韩另类电影网站| 三级国产精品片| 韩国高清视频一区二区三区| 亚洲欧美日韩另类电影网站| 国产69精品久久久久777片| 啦啦啦啦在线视频资源| 91精品国产九色| 极品教师在线视频| 三上悠亚av全集在线观看 | 日韩人妻高清精品专区| 久久免费观看电影| 天天操日日干夜夜撸| 欧美三级亚洲精品| 91久久精品电影网| 久久热精品热| 亚洲精品视频女| 只有这里有精品99| 日本av免费视频播放| 一区二区av电影网| 日韩大片免费观看网站| 亚洲欧洲日产国产| 国产男女内射视频| 伦理电影免费视频| 久久综合国产亚洲精品| 久久久久人妻精品一区果冻| 日本av手机在线免费观看| 天堂8中文在线网| 亚洲婷婷狠狠爱综合网| 国产亚洲精品久久久com| 婷婷色综合www| 国产精品99久久99久久久不卡 | 日本猛色少妇xxxxx猛交久久| 夫妻午夜视频| 国精品久久久久久国模美| 国产精品熟女久久久久浪| 欧美xxxx性猛交bbbb| 欧美成人精品欧美一级黄| 久久精品国产a三级三级三级| 中文字幕久久专区| 国产又色又爽无遮挡免| 成年女人在线观看亚洲视频| 能在线免费看毛片的网站| 国产成人aa在线观看| 丝袜脚勾引网站| 午夜激情福利司机影院| 极品教师在线视频| 极品少妇高潮喷水抽搐| 久久精品熟女亚洲av麻豆精品| 亚洲欧美成人精品一区二区| 久久久久久久久久成人| 国产白丝娇喘喷水9色精品| 国产熟女欧美一区二区| 亚洲精品久久久久久婷婷小说| 国产熟女午夜一区二区三区 | 美女国产视频在线观看| 免费久久久久久久精品成人欧美视频 | 26uuu在线亚洲综合色| 少妇丰满av| 爱豆传媒免费全集在线观看| 狂野欧美激情性xxxx在线观看| 久久精品久久精品一区二区三区| 中文字幕精品免费在线观看视频 | 亚洲熟女精品中文字幕| 草草在线视频免费看| 日韩大片免费观看网站| 天堂8中文在线网| 国产精品熟女久久久久浪| 国产精品一二三区在线看| 中文字幕亚洲精品专区| 精品亚洲乱码少妇综合久久| 国产欧美日韩精品一区二区| 久久av网站| 九九在线视频观看精品| 天天躁夜夜躁狠狠久久av| 街头女战士在线观看网站| 亚洲综合色惰| 亚洲欧洲精品一区二区精品久久久 | 国产精品蜜桃在线观看| 亚洲av在线观看美女高潮| 久久这里有精品视频免费| 精品人妻熟女毛片av久久网站| 波野结衣二区三区在线| 男的添女的下面高潮视频| 国产熟女午夜一区二区三区 | 一级a做视频免费观看| 色视频在线一区二区三区| 午夜福利影视在线免费观看| 99热6这里只有精品| 99久久人妻综合| 欧美老熟妇乱子伦牲交| 欧美区成人在线视频| 一级,二级,三级黄色视频| 少妇人妻久久综合中文| 久久ye,这里只有精品| videossex国产| 热re99久久精品国产66热6| 久久国产精品男人的天堂亚洲 | 日本黄色片子视频| 美女中出高潮动态图| 欧美日本中文国产一区发布| 天天躁夜夜躁狠狠久久av| 18禁裸乳无遮挡动漫免费视频| av国产精品久久久久影院| 免费黄色在线免费观看| 欧美精品高潮呻吟av久久| 久久女婷五月综合色啪小说| 久久99精品国语久久久| 午夜激情久久久久久久| 精品少妇内射三级| 免费看av在线观看网站| 日韩精品免费视频一区二区三区 | 人人澡人人妻人| 中文乱码字字幕精品一区二区三区| 中文字幕免费在线视频6| 国产精品人妻久久久久久| 中文字幕人妻丝袜制服| 视频区图区小说| 狂野欧美激情性xxxx在线观看| 午夜福利影视在线免费观看| 女的被弄到高潮叫床怎么办| 色5月婷婷丁香| 亚洲欧美精品自产自拍| 精品一区二区免费观看| 日本猛色少妇xxxxx猛交久久| 大香蕉97超碰在线| 色视频在线一区二区三区| 亚洲综合色惰| 国产成人freesex在线| 久久午夜福利片| 日韩 亚洲 欧美在线| 国产无遮挡羞羞视频在线观看| 国产精品一二三区在线看| 少妇猛男粗大的猛烈进出视频| 2021少妇久久久久久久久久久| 国产无遮挡羞羞视频在线观看| 99久久精品一区二区三区| 伦精品一区二区三区| 九草在线视频观看| 亚洲欧美精品自产自拍| 午夜av观看不卡| 亚洲怡红院男人天堂| 各种免费的搞黄视频| 一级a做视频免费观看| 亚洲国产欧美在线一区| 色吧在线观看| 一边亲一边摸免费视频| 我的女老师完整版在线观看| 2018国产大陆天天弄谢| 一区在线观看完整版| 成人美女网站在线观看视频| 久久亚洲国产成人精品v| 久久精品国产a三级三级三级| 精品人妻熟女毛片av久久网站| 3wmmmm亚洲av在线观看| 欧美日韩亚洲高清精品| 日本猛色少妇xxxxx猛交久久| 免费看av在线观看网站| 熟妇人妻不卡中文字幕| 日韩一区二区视频免费看| 精品少妇黑人巨大在线播放| 最近中文字幕2019免费版| 亚洲激情五月婷婷啪啪| 亚洲欧洲国产日韩| 国产精品三级大全| 国产黄片视频在线免费观看| 成人无遮挡网站| 人妻少妇偷人精品九色| 青春草视频在线免费观看| 精品国产一区二区三区久久久樱花| av播播在线观看一区| 国产一区二区在线观看av| 日本猛色少妇xxxxx猛交久久| 极品人妻少妇av视频| 亚洲怡红院男人天堂| 久久精品久久久久久噜噜老黄| freevideosex欧美| 91aial.com中文字幕在线观看| a级片在线免费高清观看视频| 丁香六月天网| 国产乱人偷精品视频| 久久精品国产a三级三级三级| 一级a做视频免费观看| 少妇人妻一区二区三区视频| 爱豆传媒免费全集在线观看| 国产黄片视频在线免费观看| 久久久久视频综合| 日本av手机在线免费观看| 久久久久精品久久久久真实原创| 成人特级av手机在线观看| 色吧在线观看| 久久影院123| 亚洲精品乱久久久久久| 国产精品欧美亚洲77777| 久久久久久伊人网av| 精华霜和精华液先用哪个| 国产成人精品久久久久久| 午夜福利在线观看免费完整高清在| 天天躁夜夜躁狠狠久久av| 日韩中字成人| 欧美精品一区二区免费开放| 精品国产露脸久久av麻豆| 精品国产乱码久久久久久小说| 各种免费的搞黄视频| 国产高清有码在线观看视频| 国产成人免费无遮挡视频| 欧美日韩国产mv在线观看视频| 国模一区二区三区四区视频| av在线播放精品| 人人妻人人澡人人看| 亚洲综合精品二区| 夫妻性生交免费视频一级片| 国产精品久久久久久精品电影小说| 免费在线观看成人毛片| 十八禁高潮呻吟视频 | 午夜免费男女啪啪视频观看| 在线精品无人区一区二区三| 免费av不卡在线播放| 国产亚洲5aaaaa淫片| 成人亚洲欧美一区二区av| 国产黄色免费在线视频| 大话2 男鬼变身卡| 婷婷色综合www| 一二三四中文在线观看免费高清| 在线 av 中文字幕| 久久久久精品性色| 一区二区三区乱码不卡18| 日本爱情动作片www.在线观看| 国产精品久久久久久av不卡| 美女福利国产在线| 少妇 在线观看| 国产免费一区二区三区四区乱码| 国内精品宾馆在线| 国产精品一区www在线观看| 国产免费视频播放在线视频| 人妻人人澡人人爽人人| 国产综合精华液| 在线观看免费高清a一片| 国产精品免费大片| 我要看黄色一级片免费的| 亚洲精品国产av成人精品| 在线 av 中文字幕| 国产精品99久久99久久久不卡 | 精品视频人人做人人爽| 乱系列少妇在线播放| 国产91av在线免费观看| 免费看av在线观看网站| 免费黄网站久久成人精品| av线在线观看网站| 日韩视频在线欧美| 欧美日韩av久久| 99热6这里只有精品| 国产老妇伦熟女老妇高清| 老熟女久久久| 免费大片18禁| 精品少妇久久久久久888优播| 国产亚洲欧美精品永久| 国产免费一区二区三区四区乱码| 日韩成人av中文字幕在线观看| xxx大片免费视频| 综合色丁香网| 一级二级三级毛片免费看| 久久午夜综合久久蜜桃| 夜夜骑夜夜射夜夜干| 久久午夜综合久久蜜桃| 国产精品免费大片| 99久久综合免费| 麻豆成人午夜福利视频| 在线免费观看不下载黄p国产| 亚洲av不卡在线观看| 日韩电影二区| 色视频www国产| 亚洲不卡免费看| 日日爽夜夜爽网站| 国产一区二区在线观看日韩| 十分钟在线观看高清视频www | 9色porny在线观看| 国产亚洲午夜精品一区二区久久| 亚洲精品色激情综合| 精品午夜福利在线看| 一级二级三级毛片免费看| 国产高清有码在线观看视频| 2021少妇久久久久久久久久久| 亚洲美女搞黄在线观看| 国产在线视频一区二区| 亚洲欧美日韩东京热| 只有这里有精品99| 亚洲成人av在线免费| 日韩伦理黄色片| 最新中文字幕久久久久| 一级毛片电影观看| 国产日韩一区二区三区精品不卡 | 久久99蜜桃精品久久| 搡老乐熟女国产| 亚洲av免费高清在线观看| 美女视频免费永久观看网站| 日韩在线高清观看一区二区三区| 波野结衣二区三区在线| 久久99精品国语久久久| 日韩大片免费观看网站| 插阴视频在线观看视频| 妹子高潮喷水视频| 久久婷婷青草| 男女免费视频国产| 精品久久久久久电影网| 亚洲精品国产成人久久av| 黑人高潮一二区| 午夜老司机福利剧场| 少妇 在线观看| 亚洲欧美中文字幕日韩二区| 啦啦啦啦在线视频资源| 亚洲精品乱码久久久v下载方式| 中文资源天堂在线| 日韩电影二区| 成人综合一区亚洲| 国产成人精品久久久久久| 国产精品人妻久久久影院| av国产精品久久久久影院| 狠狠精品人妻久久久久久综合| 亚洲欧美一区二区三区黑人 | 男的添女的下面高潮视频| 街头女战士在线观看网站| 视频区图区小说| 欧美少妇被猛烈插入视频| 九九久久精品国产亚洲av麻豆| 丰满迷人的少妇在线观看| 精品一区二区三区视频在线| 中文字幕免费在线视频6| 亚洲久久久国产精品| 一级毛片 在线播放| 亚洲欧洲精品一区二区精品久久久 | 成人毛片a级毛片在线播放| 亚洲精品久久久久久婷婷小说| 亚洲熟女精品中文字幕| 久久久国产一区二区| 亚洲精品乱久久久久久| 日本av手机在线免费观看| 日本黄色日本黄色录像| 亚洲性久久影院| 看十八女毛片水多多多| 看非洲黑人一级黄片| 99热网站在线观看| 中文字幕精品免费在线观看视频 | 久久久久久久久久久丰满| 欧美激情极品国产一区二区三区 | 国产精品三级大全| 国产精品久久久久久精品电影小说| 精品人妻熟女av久视频| 蜜桃在线观看..| 高清午夜精品一区二区三区| 汤姆久久久久久久影院中文字幕| 偷拍熟女少妇极品色| 国产视频首页在线观看| 少妇人妻精品综合一区二区| 欧美高清成人免费视频www| 欧美激情极品国产一区二区三区 | 在线天堂最新版资源| 自拍欧美九色日韩亚洲蝌蚪91 | 在线观看人妻少妇| 纵有疾风起免费观看全集完整版| 久久精品久久久久久噜噜老黄| 国产免费一区二区三区四区乱码| 97精品久久久久久久久久精品| 久久久国产欧美日韩av| 肉色欧美久久久久久久蜜桃| 五月伊人婷婷丁香| 国产精品欧美亚洲77777| av在线播放精品| 精品亚洲成国产av| 黄色配什么色好看| 熟女电影av网| 2018国产大陆天天弄谢| 热99国产精品久久久久久7| 日本91视频免费播放| 久久毛片免费看一区二区三区| 亚洲激情五月婷婷啪啪| 久久久精品94久久精品| 亚洲欧洲日产国产| a级毛色黄片| 亚洲av在线观看美女高潮| 欧美三级亚洲精品| 精品久久久久久久久av| 嫩草影院入口| 最近的中文字幕免费完整| 美女中出高潮动态图| 国产有黄有色有爽视频| 少妇的逼好多水| 下体分泌物呈黄色| 久久国产精品男人的天堂亚洲 | 精品国产露脸久久av麻豆| 欧美bdsm另类| 26uuu在线亚洲综合色| 99久久综合免费| 免费少妇av软件| 久久精品久久久久久噜噜老黄| 男女边摸边吃奶| 桃花免费在线播放| 夜夜骑夜夜射夜夜干| 日韩视频在线欧美| av网站免费在线观看视频| 丰满乱子伦码专区| 亚洲国产成人一精品久久久| 欧美日韩综合久久久久久| 亚洲国产av新网站| 国产美女午夜福利| 久久久久网色| 精品人妻一区二区三区麻豆| 国产精品.久久久| 国产欧美日韩综合在线一区二区 | 成人无遮挡网站| 成人综合一区亚洲| 成人毛片60女人毛片免费| 噜噜噜噜噜久久久久久91| 国产69精品久久久久777片| 成年人免费黄色播放视频 | 免费观看av网站的网址| 日本猛色少妇xxxxx猛交久久| 一级黄片播放器| 在线播放无遮挡| 国产一区二区在线观看日韩| videossex国产| 国产色爽女视频免费观看| 男的添女的下面高潮视频| 亚洲国产精品一区三区| 老司机亚洲免费影院| 日韩欧美一区视频在线观看 | 国产国拍精品亚洲av在线观看| 成人无遮挡网站| 国产伦精品一区二区三区四那| 久久国产乱子免费精品| 国产高清有码在线观看视频| 国产深夜福利视频在线观看| 伊人亚洲综合成人网| 国产欧美日韩综合在线一区二区 | 亚洲国产色片| 欧美+日韩+精品| 美女国产视频在线观看| 久久韩国三级中文字幕| 欧美成人精品欧美一级黄| 99精国产麻豆久久婷婷| 最近最新中文字幕免费大全7| 久久久久国产精品人妻一区二区| 亚洲久久久国产精品| 少妇人妻 视频| 曰老女人黄片| 精品少妇黑人巨大在线播放| 极品人妻少妇av视频| 五月天丁香电影| 中文资源天堂在线| 亚洲怡红院男人天堂| 在现免费观看毛片| 黄色欧美视频在线观看| 亚洲激情五月婷婷啪啪| 久久精品久久精品一区二区三区| 老女人水多毛片| 日韩av在线免费看完整版不卡| 色视频在线一区二区三区| 在线观看www视频免费| 波野结衣二区三区在线| 国产成人精品婷婷| 免费在线观看成人毛片| 国产白丝娇喘喷水9色精品| 一级片'在线观看视频| 国产视频内射| 波野结衣二区三区在线| 一级片'在线观看视频| 超碰97精品在线观看| 欧美区成人在线视频| 成人特级av手机在线观看| 亚洲av免费高清在线观看| 国产伦理片在线播放av一区| 日韩不卡一区二区三区视频在线| 老司机亚洲免费影院| 中文资源天堂在线| 一区二区三区精品91| 久久国产亚洲av麻豆专区| 亚洲第一av免费看| 国产 一区精品| 中文字幕精品免费在线观看视频 | 成人亚洲精品一区在线观看| 有码 亚洲区| 国产精品伦人一区二区| 国产成人精品福利久久| 大片电影免费在线观看免费| 欧美 日韩 精品 国产| 欧美日韩综合久久久久久| 国产男人的电影天堂91| 极品教师在线视频| 天天操日日干夜夜撸| 国精品久久久久久国模美| 精品久久久噜噜| 欧美日韩精品成人综合77777| 国产淫片久久久久久久久| 精品人妻熟女毛片av久久网站| 美女国产视频在线观看| 麻豆精品久久久久久蜜桃| 色94色欧美一区二区| 亚洲精品国产成人久久av| 中文字幕人妻熟人妻熟丝袜美| 国产黄色免费在线视频| 王馨瑶露胸无遮挡在线观看| 看十八女毛片水多多多| 亚洲精品色激情综合| 欧美成人精品欧美一级黄| 日韩av不卡免费在线播放| 春色校园在线视频观看| 99re6热这里在线精品视频| 少妇的逼好多水| 高清毛片免费看| 精品国产一区二区久久| 免费在线观看成人毛片| 天堂中文最新版在线下载| 黄色怎么调成土黄色| 久久狼人影院| 最新中文字幕久久久久| 国产精品国产三级国产专区5o| 欧美xxⅹ黑人| 我要看日韩黄色一级片| 欧美老熟妇乱子伦牲交| 国产亚洲91精品色在线| 自线自在国产av| 全区人妻精品视频| 美女福利国产在线| 亚洲无线观看免费| av福利片在线| 老司机亚洲免费影院| 亚洲经典国产精华液单| 99九九线精品视频在线观看视频| 午夜福利,免费看| 欧美国产精品一级二级三级 | 亚洲真实伦在线观看| 欧美 亚洲 国产 日韩一| 五月开心婷婷网| 成人18禁高潮啪啪吃奶动态图 | 综合色丁香网| 国产成人精品一,二区| 日本色播在线视频| 国内精品宾馆在线| 久久久久久久久久人人人人人人| 一区二区三区免费毛片| 不卡视频在线观看欧美| 在线观看美女被高潮喷水网站| 岛国毛片在线播放| 狂野欧美激情性xxxx在线观看| 久久久欧美国产精品| 天堂8中文在线网| 久久亚洲国产成人精品v| av一本久久久久| 国产欧美日韩精品一区二区| 久久久久人妻精品一区果冻| 国产精品一区二区三区四区免费观看| 精品久久久精品久久久| 边亲边吃奶的免费视频| 久久精品久久久久久久性| 亚洲怡红院男人天堂| 国产淫语在线视频| 在线观看美女被高潮喷水网站| 夫妻性生交免费视频一级片| 麻豆成人午夜福利视频| av播播在线观看一区| 99热全是精品| 欧美日韩在线观看h| 超碰97精品在线观看| 国产av精品麻豆| av女优亚洲男人天堂| 欧美三级亚洲精品| 国产在视频线精品| 成人亚洲欧美一区二区av| 成年人午夜在线观看视频| 天天操日日干夜夜撸| 啦啦啦啦在线视频资源| 亚洲精品,欧美精品| 下体分泌物呈黄色| 日日啪夜夜撸|